International Clinical Trial: A Single-Arm, Open-Label Clinical Study of Aumolertinib Monotherapy as Long-Cycle Neoadjuvant Treatment for Stage IB-?B EGFR-Positive Non-Small Cell Lung Cancer

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115235) titled 'A Single-Arm, Open-Label Clinical Study of Aumolertinib Monotherapy as Long-Cycle Neoadjuvant Treatment for Stage IB-?B EGFR-Positive Non-Small Cell Lung Cancer' on Dec. 24, 2025.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The First Affiliated Hospital of Zhengzhou University

Condition: Stage IB-?B EGFR-Positive Non-Small Cell Lung Cancer

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-01-01

Target Sample Size: Intervention group:30;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=296376

P...